Silvercrest Asset Management’s TELA Bio TELA Stock Holding History

Silvercrest Asset Management’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-396,585	Closed	-$4.61M	–	852
2022 Q1	$4.61M	Buy	396,585 +3,610	+0.9%	+$43.7K	0.03%	388
2021 Q4	$5.03M	Hold	392,975	–	–	0.03%	376
2021 Q3	$5.37M	Sell	392,975 -8,991	-2%	-$125K	0.04%	375
2021 Q2	$6.48M	Buy	401,966 +159,530	+66%	+$2.19M	0.04%	351
2021 Q1	$3.61M	Sell	242,436 -29,906	-11%	-$450K	0.02%	423
2020 Q4	$4.1M	Sell	272,342 -46,510	-15%	-$755K	0.03%	385
2020 Q3	$5.27M	Sell	318,852 -6,148	-2%	-$86.3K	0.05%	329
2020 Q2	$4.21M	Buy	+325,000	New	+$4.27M	0.04%	361

Other funds holding TELA

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

HLA

Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

Silvercrest Asset Management's TELA Position: Q2 2022 in Review

Silvercrest Asset Management sold out of TELA Bio (TELA) in Q2 2022, closing a stake of 396,585 shares — an estimated $4.61M sold.

Silvercrest Asset Management first reported a position in TELA in Q2 2020 and held it in 8 quarters. The position peaked at $6.48M in Q2 2021. 32 funds tracked by Wall St. Rank hold TELA as of Q2 2022.

Silvercrest Asset Management reported no remaining TELA Bio position as of Q2 2022 after selling out during the quarter.
Silvercrest Asset Management sold 396,585 TELA Bio shares in Q2 2022, an estimated $4.61M.
Silvercrest Asset Management first reported a position in TELA Bio in Q2 2020 and held it in 8 quarters.
Silvercrest Asset Management's TELA Bio position peaked at $6.48M in Q2 2021.
32 funds tracked by Wall St. Rank held TELA Bio as of Q2 2022.

Based on Silvercrest Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.